The DOI matches its Crossref record; 348 of the 348 references it cites were found in a registry or an index.
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Open accessAbstract
Biomarkers are vital in healthcare as they provide valuable insights into disease diagnosis, prognosis, treatment response, and personalized medicine. They serve as objective indicators, enabling early detection and intervention, leading to improved patient outcomes and reduced costs. Biomarkers also guide treatment decisions by predicting disease outcomes and facilitating individualized treatment plans. They play a role in monitoring disease progression, adjusting treatments, and detecting early signs of recurrence. Furthermore, biomarkers enhance drug development and clinical trials by identifying suitable patients and accelerating the approval process. In this review paper, we described a variety of biomarkers applicable for cancer detection and diagnosis, such as imaging-based diagnosis (CT, SPECT, MRI, and PET), blood-based biomarkers (proteins, genes, mRNA, and peptides), cell imaging-based diagnosis (needle biopsy and CTC), tissue imaging-based diagnosis (IHC), and genetic-based biomarkers (RNAseq, scRNAseq, and spatial transcriptomics).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–348 of 348
Morris, V., Overman, M. J., Jiang, Z.-Q., Garrett, C., Agarwal, S., Eng, C., Kee, B., Fogelman, D., Dasari, A., Wolff, R., et al. (2014) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2014.06.001 · Cited by 132
Lee, S., de Boer, W. B., Fermoyle, S., Platten, M., & Kumarasinghe, P. M. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04017.x · Cited by 132
Song, S., Ji, B., Ramachandran, V., Wang, H., Hafley, M., Logsdon, C. D., & Bresalier, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042699 · Cited by 131
Salivary MicroRNA in Pancreatic Cancer Patients
Humeau, M., Vignolle‐Vidoni, A., Sicard, F., Martins, F., Bournet, B., Buscail, L., Torrisani, J., & Cordelier, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130996 · Cited by 129
Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer
Liao, Y., Grobholz, R., Abel, U. R., Trojan, L., Michel, M. S., Angel, P. E., & Mayer, D. (2003) · International Journal of Cancer · doi:10.1002/ijc.11471 · Cited by 127
Schmitz, M., Grignard, G., Margue, C., Dippel, W., Capesius, C., Mossong, J., Nathan, M., Giacchi, S., Scheiden, R., & Kieffer, N. (2006) · International Journal of Cancer · doi:10.1002/ijc.22359 · Cited by 126
Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer
Capo‐chichi, C. D., Cai, K. Q., Smedberg, J. L., Ganjei‐Azar, P., Godwin, A. K., & Xu, X. (2011) · 癌症:英文版 · doi:10.5732/cjc.010.10566 · Cited by 126
CA 19-9 as a Marker for Gastrointestinal Cancers: A Review
Duffy, M. J. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500304 · Cited by 126
The role of exosomes in tumor progression and metastasis (Review)
Suchorska, W. M., & Lach, M. (2015) · Oncology Reports · doi:10.3892/or.2015.4507 · Cited by 125
Ceramide-induced cell death in malignant cells
Carpinteiro, A., Dumitru, C. A., Schenck, M., & Gulbins, E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.020 · Cited by 122
Prasad, V. K., & Kaestner, V. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.06.007 · Cited by 122
Galectin‐4 functions as a tumor suppressor of human colorectal cancer
Satelli, A., Rao, P. S., Thirumala, S. D., & Rao, U. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25750 · Cited by 120
Wang, S. E., Shin, I., Wu, F. Y., Friedman, D. B., & Arteaga, C. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2071 · Cited by 119
Kim, J., Kim, T. Y., Lee, M., Mun, J. Y., Ihm, C., & Kim, S. A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.124 · Cited by 118
Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma.
Mansh, M. D. (2011) · PubMed Central · Cited by 116
Breast cancer biomarkers and molecular medicine
Ross, J. S., Linette, G. P., Stec, J. J., Clark, E. A., Ayers, M., Leschly, N., Symmans, W. F., Hortobágyi, G. N., & Pusztai, L. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.5.573 · Cited by 113
Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer
Li, L., Du, Y., Kong, X., Li, Z., Jia, Z., Cui, J., Gao, J., Wang, G., & Xie, K. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3630 · Cited by 113
Wazir, U., Ahmed, M. H., Bridger, J. M., Harvey, A., Jiang, W. G., Sharma, A. K., & Mokbel, K. (2013) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-013-0109-9 · Cited by 112
In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer
Kather, J. N., Poleszczuk, J., Suarez‐Carmona, M., Krisam, J., Charoentong, P., Valous, N. A., Weis, C., Tavernar, L., Leiß, F., Herpel, E., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2006 · Cited by 111
Zhao, W., Ajani, J. A., Guha, S., Ochi, N., Hwang, R. F., Hafley, M., Johnson, R. L., Bresalier, R. S., Logsdon, C. D., Zhang, Z., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.12.014 · Cited by 111
Chen, C., Duckworth, C. A., Zhao, Q., Pritchard, D. M., Rhodes, J. M., & Yu, L. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2940 · Cited by 110
Yan, W., Fu, Y., Tian, D., Liao, J., Liu, M., Wang, B., Xia, L., Zhu, Q., & Luo, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.088 · Cited by 107
Mac‐2‐binding protein is a diagnostic marker for biliary tract carcinoma
Koopmann, J., Thuluvath, P. J., ZAHURAK, M. L., Kristiansen, T. Z., Pandey, A., Schulick, R. D., Argani, P., Hidalgo, M. M., Iacobelli, S., Goggins, M., et al. (2004) · Cancer · doi:10.1002/cncr.20469 · Cited by 106
Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling
Ledeen, R. W., & Wu, G. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800009-jlr200 · Cited by 105
Ki-67 is required for maintenance of cancer stem cells but not cell proliferation
Cidado, J. R., Wong, H. Y., Rosen, D. M., Cimino‐Mathews, A., Garay, J. P., Fessler, A. G., Rasheed, Z. A., Hicks, J. L., Cochran, R. L., Croessmann, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7057 · Cited by 105
Tatli, S., Gerbaudo, V. H., Mamede, M., Tuncali, K., Shyn, P. B., & Silverman, S. G. (2010) · Radiology · doi:10.1148/radiol.10090931 · Cited by 103
Mesenchymal stem cell-derived exosomes facilitate nasopharyngeal carcinoma progression.
Shi, S., Zhang, Q., Xia, Y., You, B., Shan, Y., Bao, L., Li, L., You, Y., & Gu, Z. (2016) · PubMed · Cited by 103
Salivary biomarkers in the diagnosis of breast cancer: A review
Mascarenhas, E. C. P., Assad, D. X., Chardin, H., Gozal, D., Canto, G. D. L., Acevedo, A. C., & Guerra, E. N. S. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.12.009 · Cited by 103
Resistance mechanisms to targeted therapy in BRAF-mutant melanoma - A mini review
Tangella, L. P., Clark, M. E., & Gray, E. S. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129736 · Cited by 103
Koyama, Y., Barrett, T., Hama, Y., RAVIZZINI, G. C., Choyke, P. L., & Kobayashi, H. (2007) · Neoplasia · doi:10.1593/neo.07787 · Cited by 101
Magnetic Resonance Spectroscopy in Metabolic and Molecular Imaging and Diagnosis of Cancer
Glunde, K., Artemov, D., Penet, M., Jacobs, M. A., & Bhujwalla, Z. M. (2010) · Chemical Reviews · doi:10.1021/cr9004007 · Cited by 101
Tilli, C. M. L. J., Ramaekers, F. C. S., Broers, J. L. V., Hutchison, C. J., & Neumann, H. A. M. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05026.x · Cited by 100
miR-18a Inhibits CDC42 and Plays a Tumour Suppressor Role in Colorectal Cancer Cells
Humphreys, K. J., McKinnon, R. A., & Michael, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112288 · Cited by 98
Demharter, J., Müller, P. E., Wagner, T., Schlimok, G., Haude, K.-H., & Bohndorf, K. (2001) · European Radiology · doi:10.1007/s003300000540 · Cited by 98
Kuo, P.-L., Hung, J., Huang, S.-K., Chou, S., Cheng, D.-E., Jong, Y., Hung, C., Yang, C., Tsai, Y., Hsu, Y.-L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002940 · Cited by 98
Proteomic analysis of cancer-cell mitochondria
Verma, M., Kagan, J., Sidransky, D., & Srivastava, S. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1192 · Cited by 94
Regulation of T‐cell responses by PTEN
Buckler, J. L., Liu, X., & Turka, L. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00650.x · Cited by 93
Barwick, T. D., Bencherif, B., Mountz, J. M., & Avril, N. E. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32832ee93b · Cited by 93
The clinical application of proteomics
Colantonio, D., & Chan, D. W. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.03.020 · Cited by 92
Expanding medicinal chemistry space
Barker, A. J., Kettle, J. G., Nowak, T., & Pease, J. E. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.008 · Cited by 91
Landgren, O., Porwit‐MacDonald, A., Tani, E. M., Czader, M., Grimfors, G., Skoog, L. K., Öst, Å., Wedelin, C., Axdorph, U., Svedmyr, E. A. J., et al. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200316 · Cited by 91
Gulei, D., Magdo, L., Jurj, A. M., Ráduly, L., Cojocneanu, R., Moldovan, A. I., Moldovan, C. S., Florea, A., Paşca, S., Pop, L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0102-8 · Cited by 89
Prognostic Significance of Endogenous Adhesion/Growth-Regulatory Lectins in Lung Cancer
Szőke, T., Kayser, K., Baumhäkel, J.-D., Troján, I., Furák, J., Tiszlavicz, L., Horvath, A., Szluha, K., Gabius, H., & André, S. (2005) · Oncology · doi:10.1159/000087841 · Cited by 88
Diagnostic model of saliva protein finger print analysis of patients with gastric cancer
Wu, Z., Wang, J.-G., & Zhang, X. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.865 · Cited by 88
Langbein, S., Brade, J., Badawi, J. K., Hatzinger, M., Kaltner, H., Lensch, M., Specht, K., André, S., Brinck, U., Alken, P. M., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02852.x · Cited by 85
Rechreche, H., Mallo, G. V., Montalto, G., Dagorn, J., & Iovanna, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00225.x · Cited by 84
Duffy, M. J., McDermott, E. W. M., & Crown, J. P. (2018) · Tumor Biology · doi:10.1177/1010428318776169 · Cited by 83
Lee, C., Im, E.-J., Moon, P., & Baek, M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4952-y · Cited by 83
Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments
Wu, X., Qin, L., Fako, V., & Zhang, J.-T. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.004 · Cited by 82
Ouyang, J., Plütschow, A., von Strandmann, E. P., Reiners, K. S., Ponader, S., Rabinovich, G. A., Neuberg, D. S., Engert, A., & Shipp, M. A. (2013) · Blood · doi:10.1182/blood-2012-12-474569 · Cited by 82
Masaoutis, C., Mihailidou, C., Tsourouflis, G. S., & Theocharis, S. E. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.014 · Cited by 81
Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas
de Kerviler, É., de BAZELAIRE, C., Mounier, N., Mathieu, O., Brethon, B., Brière, J., Marolleau, J., Brice, P., Gisselbrecht, C., & Frija, J. (2006) · European Radiology · doi:10.1007/s00330-006-0393-0 · Cited by 80
High serum galectin-3 in advanced melanoma: preliminary results.
Vereecken, P. M., Boudjeltia, K. Z., Debray, C., Awada, A. H., Legssyer, I., Salès, F., Pétein, M., Vanhaeverbeek, M., Ghanem, G., & Heenen, M. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01992.x · Cited by 77
Pei, R., Shi, Y., Lv, S., Dai, T., Zhang, F., Liu, S., & Wu, B. Y. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8065 · Cited by 75
Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond
Uruga, H., & Mino-Kenudson, M. A. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03030-8 · Cited by 73
Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer
Kim, S. W., Park, K. C., Jeon, S. M., Ohn, T. B., Kim, T. I., Kim, W. H., & Cheon, J. H. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0124-x · Cited by 72
Serum level of galectin-3 in human bladder cancer
Sakaki, M., Oka, N., Nakanishi, R., Yamaguchi, K., Fukumori, T., & Kanayama, H. (2008) · The Journal of Medical Investigation · doi:10.2152/jmi.55.127 · Cited by 71
Lassau, N., Chapotot, L., Benatsou, B., Vilgrain, V., Kind, M., Lacroix, J., Cuinet, M., Taieb, S., Aziza, R., Sarran, A., et al. (2012) · Investigative Radiology · doi:10.1097/rli.0b013e31826dc255 · Cited by 71
Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma
Liang, M., Ueno, M., Oomizu, S., Arikawa, T., Shinonaga, R., Zhang, S., Yamauchi, A., & Hirashima, M. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0352-z · Cited by 70
Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Zhang, H., Liang, X., Duan, C., Liu, C., & Zhao, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103482 · Cited by 70
Progress in research on the role of circular RNAs in lung cancer
Chen, Y., Wei, S., Wang, X., Zhu, X., & Han, S. (2018) · World Journal of Surgical Oncology · doi:10.1186/s12957-018-1515-2 · Cited by 70
André, T., Cohen, R., & Salem, M. E. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_349557 · Cited by 70
Determination of serum lysophosphatidic acid as a potential biomarker for ovarian cancer
Meleh, M., Požlep, B., Mlakar, A., et al. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.08.008 · Cited by 69
Stem cells in colon cancer. A new era in cancer theory begins
Papailiou, J., Bramis, K. J., Gazouli, M., & Theodoropoulos, G. E. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-1022-6 · Cited by 69
Roth, J. A., & Carlson, J. J. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.04.005 · Cited by 68
Galectin-1 in Melanoma Biology and Related Neo-Angiogenesis Processes
Mathieu, V., de Lassale, E. M., Toelen, J., Mohr, T. T., Bellahcène, A., Goietsenoven, G. V., Verschuere, T., Bouzin, C., Debyser, Z., Vleeschouwer, S. D., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.142 · Cited by 68
Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas
Mirchia, K., & Richardson, T. E. (2020) · Cancers · doi:10.3390/cancers12071817 · Cited by 68
Chiariotti, L., Berlingieri, M. T., Battaglia, C., Benvenuto, G., Martelli, M. L., Salvatore, P., Chiappettaxy, G., Bruni, C. B., & Fusco, A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640305 · Cited by 67
Baldus, S. E., Zirbes, T. K., Weingarten, M., Fromm, S., Glossmann, J.-P., Hanisch, F., ̈nig, S. P. M., der, W. S. X. F., Flucke, U., Thiele, J., et al. (2000) · Tumor Biology · doi:10.1159/000030131 · Cited by 67
Stem Cells in Hepatocarcinogenesis: Evidence from Genomic Data
Marquardt, J. U., & Thorgeirsson, S. S. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247130 · Cited by 66
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
Soliman, H., Shah, V., Srkalovic, G., Mahtani, R., Levine, E., Mavromatis, B., Srinivasiah, J., Kassar, M., Gabordi, R., Qamar, R., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-6534-z · Cited by 65
Xin, H.-W., Hari, D. M., Mullinax, J. E., Ambe, C. M., Koizumi, T., Ray, S., Anderson, A. J., Wiegand, G. W., Garfield, S. H., Thorgeirsson, S. S., et al. (2012) · Stem Cells · doi:10.1002/stem.1061 · Cited by 62
Blood circulating tumor DNA for non‐invasive genotyping of colon cancer patients
Siravegna, G., & Bardelli, A. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.005 · Cited by 62
Molecular Imaging with Reporter Genes: Has Its Promise Been Delivered?
Serganova, I. S., & Blasberg, R. G. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.220004 · Cited by 62
Vereecken, P., Awada, A. H., Suciu, S., de Castro, G., Morandini, R., Lityń́ska, A., Líénard, D., Ezzedine, K., Ghanem, G., & Heenen, M. (2009) · Melanoma Research · doi:10.1097/cmr.0b013e32832ec001 · Cited by 61
Galectin-3: a possible complementary marker to the PSA blood test
Balan, V., Wang, Y., Nangia‐Makker, P., Kho, D., Bajaj, M., Smith, D. W., Heilbrun, L. K., Raz, A., & Heath, E. I. (2013) · Oncotarget · doi:10.18632/oncotarget.923 · Cited by 60
A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers
Langan, R. C., Mullinax, J. E., Ray, S., Raiji, M. T., Schaub, N. P., Xin, H.-W., Koizumi, T., Steinberg, S. M., Anderson, A., Wiegand, G. W., et al. (2012) · Journal of Cancer · doi:10.7150/jca.4542 · Cited by 60
Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery
Righi, M., Manfredi, R., Farneti, G., Pasquini, E., & Cenacchi, V. (1996) · Head & Neck · doi:10.1002/(sici)1097-0347(199609/10)18:5 · Cited by 60
Hood, J. L. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.07.009 · Cited by 59
Saal, I., Nagy, N., Lensch, M., Löhr, M. J., Manning, J. C., Decaestecker, C., André, S., Robert Kiss, A., Salmon, I. J., & Gabius, H. (2005) · PubMed · doi:10.14670/hh-20.1191 · Cited by 58
Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer
Yu, Z., Chen, H., Ai, J., Zhu, Y., Li, Y., Borgia, J. A., Yang, J., Zhang, J., Jiang, B., Gu, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22391 · Cited by 57
Smarter screening for prostate cancer
Tan, G. H., Nason, G. J., Ajib, K., et al. (2019) · World Journal of Urology · doi:10.1007/s00345-019-02719-5 · Cited by 56
Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading
Wulczyn, E., Nagpal, K., Symonds, M., Moran, M., Plass, M., Reihs, R., Nader, F., Tan, F., Cai, Y., Brown, T., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00005-3 · Cited by 56
MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in�vitro
Liu, J., Chen, Z., Xiang, J., & Gu, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.8069 · Cited by 55
D’Haene, N., Maris, C., Sandras, F., Dehou, M. F., Remmelink, M., Decaestecker, C., & Salmon, I. J. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800304 · Cited by 54
Circulating tumor cells in breast cancer: applications in personalized medicine
Lee, J. S., Magbanua, M. J. M., & Park, J. W. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4014-6 · Cited by 54
Piao, H., Guo, S., Wang, Y., & Zhang, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s238706 · Cited by 54
Kaufman, H. W., Alagia, D. P., Chen, Z., Oniśko, A., & Austin, R. M. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa074 · Cited by 52
The Tumor Microenvironment Modulates Choline and Lipid Metabolism
Mori, N., Wildes, F., Takagi, T., Glunde, K., & Bhujwalla, Z. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00262 · Cited by 51
miR-17-3P regulates the proliferation and survival of colon cancer cells by targeting Par4
Lu, D., Tang, L., Zhuang, Y., & Zhao, P. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7863 · Cited by 51
Neder, L., Marie, S. K. N., Carlotti, C. G., Gabbai, A. A., Rosemberg, S., Malheiros, S. M., Siqueira, R. P., Oba‐Shinjo, S. M., Uno, M., de Aguiar, P. H. P., et al. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00083.x · Cited by 50
Barboro, P., Repaci, E., D’Arrigo, C., & Balbi, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040617 · Cited by 50
Proteomic Identification of New Biomarkers and Application in Thyroid Cytology
Torres-Cabala, C. A., Bibbo, M., Panizo-Santos, Á., Barazi, H., Krutzsch, H. C., Roberts, D. D., & Merino, M. J. (2006) · Acta Cytologica · doi:10.1159/000326006 · Cited by 49
Analyzing Circulating Tumor Cells One at a Time
Ortiz, V., & Yu, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.05.004 · Cited by 48
Dolscheid‐Pommerich, R., Manekeller, S., Walgenbach‐Brünagel, G., Kalff, J. C., Hartmann, G., WAGNER, B. S., & Holdenrieder, S. (2017) · Anticancer Research · doi:10.21873/anticanres.11329 · Cited by 47
Lu, Q., Yang, Y., Jin, Y. S., Zhang, Z., Heber, D., Li, F. P., Dubinett, S. M., Sondej, M. A., Loo, J. A., & Rao, J. Y. (2009) · PROTEOMICS · doi:10.1002/pmic.200800019 · Cited by 46
Chiao (2009) · International Journal of Oncology · doi:10.3892/ijo_00000459 · Cited by 46
Chau, V., & Bilušić, M. (2020) · Cancer Management and Research · doi:10.2147/cmar.s216605 · Cited by 46
Haan, J. C., Bhaskaran, R., Ellappalayam, A., Bijl, Y., Griffioen, C. J., Lujinovic, E., Audeh, W. M., Penault-Llorca, F. M., Mittempergher, L., & Glas, A. M. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23014 · Cited by 46
Application of mitochondrial genome information in cancer epidemiology
Verma, M., & Kumar, D. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.018 · Cited by 45
Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients
Iacovazzi, P. A., Notarnicola, M., Caruso, M. G., Guerra, V., Frisullo, S., Altomare, D. F., & Correale, M. (2009) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970902936880 · Cited by 45
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer
Nava, G. M., & Pérez, L. A. M. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2065196 · Cited by 43
Lamberti, I., Scarano, S., Esposito, C. L., Antoccia, A., Antonini, G., Tanzarella, C., de Franciscis, V., & Minunni, M. (2015) · Methods · doi:10.1016/j.ymeth.2015.10.022 · Cited by 42
Čada, Z., Smetana, K., Lacina, L., Plzáková, Z., Štork, J., Kaltner, H., Russwurm, R., Lensch, M., André, S., & Gabius, H. (2009) · Folia Biologica · doi:10.14712/fb2009055040145 · Cited by 42
Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and Survival
Dauphine, C., Moazzez, A., Neal, J. C., Chlebowski, R. T., & Ozao‐Choy, J. J. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08898-5 · Cited by 42
Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives
Aleksakhina, S. N., & Imyanitov, E. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010931 · Cited by 41
Tripathi, K. K., Mani, C., Barnett, R. M., Nalluri, S., Bachaboina, L., Rocconi, R. P., Athar, M., Owen, L. B., & Palle, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.606483 · Cited by 41
Sklair‐Levy, M., Amir, G., Spectre, G., Lebensart, P., Applbaum, Y. H., Agid, R., Lieberman, S., Ben‐Yehuda, D., Sherman, Y., & Libson, E. (2005) · Journal of Computer Assisted Tomography · doi:10.1097/01.rct.0000161423.72754.0d · Cited by 40
Chemical biology approaches to target validation in cancer
Blagg, J., & Workman, P. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.07.007 · Cited by 40
Cludts, S., Decaestecker, C., Mahillon, V., Chevalier, D., Kaltner, H., André, S., Remmelink, M., Leroy, X., Gabius, H., & Saussez, S. (2009) · PubMed · Cited by 40
p16 inactivation in small-sized lung adenocarcinoma: Its association with poor prognosis
Kawabuchi, B., Moriyama, S., Hironaka, M., Fujii, T., Koike, M., Moriyama, H., Nishimura, Y., Mizuno, S., & Fukayama, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990219)84:1<39::aid-ijc8>3.0.co;2-e · Cited by 39
Pembrolizumab in MSI-H–dMMR Advanced Colorectal Cancer — A New Standard of Care
Grothey, A. F. (2020) · New England Journal of Medicine · doi:10.1056/nejme2031294 · Cited by 39
Elshazly, A. M., & Gewirtz, D. A. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2022.09 · Cited by 39
Minton, D. R., Fu, L., Chen, Q., Robinson, B. D., Gross, S. S., Nanus, D. M., & Gudas, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120649 · Cited by 37
Kondoh, N., Hada, A., Ryo, A., Shuda, M., Arai, M., Matsubara, O., Kimura, F., Wakatsuki, T., & Yamamoto, M. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.6.1575 · Cited by 37
Xue, D., Xia, T., Wang, J., Chong, M., Wang, S., & Zhang, C. (2018) · Oncology Letters · doi:10.3892/ol.2018.8993 · Cited by 37
Kim, S. J., Lee, S. J., Sung, H. J., Choi, I. K., Choi, C. W., Kim, B. S., Kim, J. S., Yu, W., Hwang, H. S., & Kim, I. S. (2008) · Acta Haematologica · doi:10.1159/000193223 · Cited by 36
Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma
Wollina, U., Graefe, T., Feldrappe, S., André, S., Wasano, K., Kaltner, H., Zick, Y., & Gabius, H. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-001-0304-3 · Cited by 36
Proteomic biomarkers in body fluids associated with pancreatic cancer
Jiménez‐Luna, C., Torres, C., Ortíz, R., Diéguez-Castillo, C., Martínez-Galán, J., Melguizo, C., Prados, J. C., & Caba, O. (2018) · Oncotarget · doi:10.18632/oncotarget.24654 · Cited by 36
H-CNN combined with tissue Raman spectroscopy for cervical cancer detection
Kang, Z., Li, Y., Liu, J., Chen, C., Wu, W., Chen, C., Lv, X., & Liang, F. (2023) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2023.122339 · Cited by 35
Increased expression of galectin-1 during the progression of cervical neoplasia
Kohrenhagen, N., Volker, H. U., Kapp, M., Dietl, J., & Kämmerer, U. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00741.x · Cited by 33
Hellyer, J. A., White, M. N., Gardner, R. M., Cunanan, K. M., Padda, S. K., Das, M. S., Ramchandran, K. J., Neal, J. W., & Wakelee, H. A. (2021) · Clinical Lung Cancer · doi:10.1016/j.cllc.2021.09.004 · Cited by 33
Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer
Yang, J., Zhu, L., Cai, Y., Suo, J., & Jin, J. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2494 · Cited by 32
Chen, S., Wang, Y., Su, Y., Zhang, L., Zhang, M., Li, X., Wang, J., & Zhang, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8650 · Cited by 32
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
Ross, K., Pailler, E., Faugeroux, V., Taylor, M., Oulhen, M., Auger, N., Planchard, D., Soria, J., Lindsay, C. R., Besse, B., et al. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1111139 · Cited by 31
Molecular Imaging in Synthetic Biology, and Synthetic Biology in Molecular Imaging
Gilad, A. A., & Shapiro, M. G. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1062-1 · Cited by 30
Discovery of Lamin B1 and Vimentin as Circulating Biomarkers for Early Hepatocellular Carcinoma
Wong, K., & Luk, J. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-959-4_19 · Cited by 29
Does phosphorylation of cofilin affect the progression of human bladder cancer?
Chung, H., Kim, B., Jung, S.-H., Won, K., Jiang, X., Lee, C., Lim, S. D., Yang, S., Song, K. H., & Kim, H. S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-45 · Cited by 29
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
von Klot, C. A., Kramer, M. W., Peters, I., Hennenlotter, J., Abbas, M., Scherer, R., Herrmann, T. R., Stenzl, A., Kuczyk, M. A., Serth, J., et al. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-15 · Cited by 29
Liu, N., Jiang, F., Han, X., Li, M., Chen, W., Qc, L., Cx, L., & Lv, Y. (2018) · PubMed · doi:10.26355/eurrev_201801_14106 · Cited by 29
Koopmans, S. M., Bot, F., Schouten, H. C., Janssen, J. W. H., & Marion, A. M. W. V. (2012) · Europe PMC (PubMed Central) · Cited by 28
Tissue Banking of Diagnostic Lung Cancer Biopsies for Extraction of High Quality RNA
Lawson, M. H., Rassl, D. M., Cummings, N. M., Russell, R., Morjaria, J. B., Brenton, J. D., Murphy, G., & Rintoul, R. C. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181ddbbe9 · Cited by 28
NUCLEAR LAMIN EXPRESSION IN NORMAL TESTIS AND TESTICULAR GERM CELL TUMOURS OF ADOLESCENTS AND ADULTS
Machiels, B. M., Ramaekers, F. C. S., Kuijpers, H. J. H., Groenewoud, J. S., Oosterhuis, J. W., & Looijenga, L. H. J. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199706)182:2<197::aid-path823>3.0.co;2-p · Cited by 28
Monaco, S. E., Wu, Y., Teot, L. A., & Cai, G. (2011) · Diagnostic Cytopathology · doi:10.1002/dc.21841 · Cited by 24
Gatti, G., Vilardo, L., Musa, C., Pietro, C. D., Bonaventura, F., Scavizzi, F., Torcinaro, A., Bucci, B., Saporito, R., Arisi, I., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101343 · Cited by 23
Makino, K., Kawamura, K., Sato, W., Kawamura, N., Fujimoto, T., & Terada, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041049 · Cited by 21
Patel, R., Bock, M., Polotti, C. F., & Elsamra, S. E. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1277204 · Cited by 20
Functional PET Imaging in Cancer Drug Development
Avril, N. E., & PROPPER, D. J. (2007) · Future Oncology · doi:10.2217/14796694.3.2.215 · Cited by 19
Haikal, A., Borba, E. F., Khaja, T., Doolittle, G. C., & Schmidt, P. (2017) · Avicenna Journal of Medicine · doi:10.4103/ajm.ajm_127_17 · Cited by 19
Diagnostic and prognostic markers in gliomas – an update
Ma, R., de Pennington, N., Hofer, M., Blesing, C., & Stacey, R. J. (2013) · British Journal of Neurosurgery · doi:10.3109/02688697.2012.752432 · Cited by 18
Predictive value of exosomes and their cargo in drug response/resistance of breast cancer patients
Schwarzenbach, H., & Gahan, P. B. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2019.90 · Cited by 18
Bernhardt, S. M., Dasari, P., Wrin, J., Raymond, W. A., Edwards, S., Walsh, D., Townsend, A. R., Price, T. J., & Ingman, W. V. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01327-1 · Cited by 16
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., & Hayes, D. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.524 · Cited by 13
Amisha, F., Malik, P., Saluja, P., Gautam, N., Patel, T. H., Roy, A. M., Singh, S. R. K., & Malapati, S. J. (2023) · Onco · doi:10.3390/onco3020008 · Cited by 13
Weissenbacher, T. M., Kühn, C., Mayr, D. C., et al. (2011) · PubMed · Cited by 12
Koc, M. A., Wiles, T. A., Weinhold, D. C., Rightmyer, S., Weaver, A. L., McDowell, C. T., Roder, J., Asmellash, S. G., Pestano, G. A., Röder, H., et al. (2023) · Journal of Mass Spectrometry and Advances in the Clinical Lab · doi:10.1016/j.jmsacl.2023.11.001 · Cited by 7
Akamine, T., Tagawa, T., Ijichi, K., Toyokawa, G., Takamori, S., Hirai, F., Okamoto, T., Oda, Y., & Maehara, Y. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-018-07137-2 · Cited by 5
Epigenetics in precision medicine of breast cancer
Natesh, J., Penta, D., & Meeran, S. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823008-4.00004-4 · Cited by 3
Cited by
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
The impact of AI on modern oncology from early detection to personalized cancer treatment
Li, J., Zhang, L., Yu, Z., Bao, Z., Li, D., & Wang, L. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01276-6 · Cited by 24
Metadata
- Authors
- Das, S., Dey, M. K., Devireddy, R., & Gartia, M. R.
- Venue
- Sensors
- Publisher
- MDPI AG
- Published
- 2023-12-20
- Volume
- 24
- Issue
- 1
- Pages
- 37
- ISSN
- 1424-8220 (ISSN-L)
- OpenAlex
- W4389992195
- Cited by
- 383
- References
- 348
- FWCI
- 37.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.